A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19
Abstract Background Many patients with severe COVID-19 have impaired glucose tolerance, and steroid therapy is a standard treatment. Thus, good glycemic control is important and correlates with better patient outcomes. We began using a continuous intravenous insulin infusion protocol for glycemic co...
Main Authors: | Yoshihito Takahashi, Hiroshi Matsuura, Hisaya Domi, Hitoshi Yamamura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Clinical Diabetes and Endocrinology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40842-022-00141-2 |
Similar Items
-
Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2023-10-01) -
Comparative study of intravenous methylprednisolone pulse therapy versus oral prednisolone minipulse therapy in progressive vitiligo
by: K A Rajeshwari, et al.
Published: (2023-01-01) -
Treatment of Methylprednisolone Allergy with Dexamethasone
by: Öner Özdemir, et al.
Published: (2017-06-01) -
The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis
by: Krzysztof Cezary Lewandowski, et al.
Published: (2024-01-01) -
Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years
by: Gesmar Volga Haddad Herdy, et al.
Published: (1999-05-01)